BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27063172)

  • 1. [Changes of serum TOS and TAS levels and their association with apolipoprotein(a) in patients with polycystic ovary syndrome and infertility].
    Tu AS; Zhong Y; Mao XG
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):405-9. PubMed ID: 27063172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxidant status on the etiopathogenesis of unexplained infertility and intracytoplasmic sperm injection - embryo transfer success: a case-control study.
    Şentürk R; Tola EN; Bozkurt M; Doğuç DK
    J Obstet Gynaecol; 2022 Jul; 42(5):1312-1318. PubMed ID: 34842027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of oxidative stress to PCOS].
    Zhang D; Luo WY; Liao H; Wang CF; Sun Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):421-3. PubMed ID: 18575330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of acupuncture as adjunctive treatment on infertility patients with polycystic ovary syndrome].
    Xu J; Zuo Y
    Zhongguo Zhen Jiu; 2018 Apr; 38(4):358-61. PubMed ID: 29696918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin.
    Cui N; Feng X; Zhao Z; Zhang J; Xu Y; Wang L; Hao G
    Clin Ther; 2017 Apr; 39(4):751-758. PubMed ID: 28291580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
    Karakurt F; Carlioglu A; Kaygusuz I; Gumus II; Uz B; Akdeniz D
    Arch Gynecol Obstet; 2014 Jan; 289(1):135-40. PubMed ID: 23880889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
    Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
    J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is There An Advantage of Using Dingkun Pill () alone or in Combination with Diane-35 for Management of Polycystic Ovary Syndrome? A Randomized Controlled Trial.
    Deng Y; Wang YF; Zhu SY; Ma X; Xue W; Ma RL; Sun AJ
    Chin J Integr Med; 2020 Dec; 26(12):883-889. PubMed ID: 32915426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study.
    Hwang JL; Seow KM; Lin YH; Huang LW; Hsieh BC; Tsai YL; Wu GJ; Huang SC; Chen CY; Chen PH; Tzeng CR
    Hum Reprod; 2004 Sep; 19(9):1993-2000. PubMed ID: 15284212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case-Control Study on the Oxidative Status in Women with Polycystic Ovary Syndrome Treated with Clomiphene Citrate.
    Yildirim E; Derici MK
    Med Sci Monit; 2019 May; 25():3910-3917. PubMed ID: 31129677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome?
    Kabil Kucur S; Gozukara I; Aksoy A; Uludag EU; Keskin H; Kamalak Z; Carlioglu A
    Blood Coagul Fibrinolysis; 2015 Dec; 26(8):862-5. PubMed ID: 25402193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The platelet activating factor acetyl hydrolase, oxidized low-density lipoprotein, paraoxonase 1 and arylesterase levels in treated and untreated patients with polycystic ovary syndrome.
    Carlioglu A; Kaygusuz I; Karakurt F; Gumus II; Uysal A; Kasapoglu B; Armutcu F; Uysal S; Keskin EA; Koca C
    Arch Gynecol Obstet; 2014 Nov; 290(5):929-35. PubMed ID: 24840107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on clinical signs of androgenization, hormone profile and ovarian size in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Balint-Perić L; Puzigaća Z
    Gynecol Endocrinol; 1989 Dec; 3(4):269-80. PubMed ID: 2516704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.
    Luque-Ramírez M; Alvarez-Blasco F; Uriol Rivera MG; Escobar-Morreale HF
    Hum Reprod; 2008 Jul; 23(7):1594-601. PubMed ID: 18375410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a low-dose estrogen-antiandrogen combination (Diane-35) on lipid and carbohydrate metabolism in patients with polycystic ovary syndrome.
    Prelević GM; Würzburger MI; Trpković D; Balint-Perić L
    Gynecol Endocrinol; 1990 Sep; 4(3):157-68. PubMed ID: 2284980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in nonobese women with polycystic ovary syndrome: correlations with endocrine and screening parameters.
    Verit FF; Erel O
    Gynecol Obstet Invest; 2008; 65(4):233-9. PubMed ID: 18196905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Diane-35, alone or in combination with orlistat or metformin in Chinese polycystic ovary syndrome patients.
    Ruan X; Song J; Gu M; Wang L; Wang H; Mueck AO
    Arch Gynecol Obstet; 2018 Jun; 297(6):1557-1563. PubMed ID: 29602978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Heavy Metal Exposure and Trace Element Levels Related to Metabolic and Endocrine Problems in Polycystic Ovary Syndrome?
    Kirmizi DA; Baser E; Turksoy VA; Kara M; Yalvac ES; Gocmen AY
    Biol Trace Elem Res; 2020 Nov; 198(1):77-86. PubMed ID: 32504400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome.
    Mhao NS; Al-Hilli AS; Hadi NR; Jamil DA; Al-Aubaidy HA
    Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S95-8. PubMed ID: 26703220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.